International Journal of Endocrinology / 2014 / Article / Tab 1

Clinical Study

Effectiveness of Multiple Daily Injections or Continuous Subcutaneous Insulin Infusion for Children with Type 1 Diabetes Mellitus in Clinical Practice

Table 1

General clinical data at baseline.

  Group 1Group 2
  Group 1AGroup 1BGroup 2AGroup 2B

Males/females (n)29/3256/660.4013/1024/220.73
Age (years)7.29 ± 3.998.61 ± 3.080.1410.50 ± 2.7810.35 ± 2.730.84
Disease duration (months)1.72 ± 2.431.77 ± 2.420.9021.09 ± 5.5421.00 ± 5.720.95
Glycosylated hemoglobin level (%)8.03 ± 1.418.01 ± 1.920.938.39 ± 1.238.67 ± 1.440.44
Abnormal glycemic control rate (%)18.022.10.5230.445.70.23
BMI (kg/m2)16.74 ± 2.2616.57 ± 1.920.6117.54 ± 1.9717.12 ± 2.450.48
Insulin dosage (U/kg/d)0.59 ± 0.360.39 ± 0.24<0.010.58 ± 0.270.66 ± 0.230.19
Blood glucose monitoring ≥4 times/day (%)76.3620.157031.30.13

*Group 1A versus group 1B; group 2A versus group 2B.